MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    Patient-reported changes from normal in individuals with prodromal and early-motor Parkinson’s disease: a scoping review

    J. Saade, T. Mestre, G. Stebbins, A. van Wyk (Ottawa, Canada)

    Objective: To synthesize published literature about patient-reported symptoms (PRS) or changes from normal in prodromal and early motor stages of Parkinson’s disease (PD) and develop…
  • 2024 International Congress

    Combined application of alpha-synuclein and 4-repeat tau seed amplification assays for the differential diagnosis of parkinsonian disorders

    E. Jabbari, E. Artikis, C. Orru`, D. Vaughan, N. Vijiaratnam, R. Fumi, M. Theilmann Jensen, M. Hodgson, T. Georgiades, L. Wu, D. Lux, R. Obrocki, B. Groveman, A. Hughson, O. Ansorge, K. Allinson, T. Warner, Z. Jaunmuktane, A. Misbahuddin, N. Leigh, B. Ghosh, K. Bhatia, A. Church, C. Kobylecki, M. Hu, J. Rowe, C. Blauwendraat, T. Foltynie, H. Morris, B. Caughey (London, United Kingdom)

    Objective: To assess alpha-synuclein (a-syn) and 4-repeat tau (4RT) seed amplification assay (SAA) positivity rates in biosamples from people with Parkinson’s disease (PD) and Progressive…
  • 2024 International Congress

    Early-onset Parkinsonism as Presenting Manifestation of CADASIL in a Mexican Woman with NOTCH3 c.1732C>T Pathogenic Variant

    M. Arbeu Reyes, B. Madariaga Cortés, S. Castillo Torres (Puebla, Mexico)

    Objective: To report the case of a patient with parkinsonism as initial symptom, secondary to an specific NOTCH3 pathogenic variant.Objective: To report the case of…
  • 2024 International Congress

    Post-stroke Movement Disorders: A Systematic Review of the Clinical Spectrum, Neuroanatomy, and Demographic Characteristics of 577 Published cases

    B. Mishra, A. Agarwal, M. Nayak, N. Nilima, P. Srivastava, V. Vishnu (South delhi, India)

    Objective: To comprehensively examine the spectrum of post-stroke movement disorders (PSMDs), with a focus on understanding their prevalence, clinical characteristics, neuroanatomical correlates, and demographic profiles…
  • 2024 International Congress

    Parkinsonism due to Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Responsive to Carbidopa/Levodopa

    P. Hoff, F. Butt (Oklahoma City, USA)

    Objective: To describe a case of Parkinsonism due to ALSP which is responsive to carbidopa/levodopa Background: Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)…
  • 2024 International Congress

    Prevalence and Spectrum of Movement Disorders in a Rural Neurology Clinic in Western India

    D. Desai, S. Udani, A. Shah, S. Desai (Anand, India)

    Objective: This study aimed to determine the prevalence and distribution of different movement disorder subtypes presenting to a rural neurology clinic. Background: Movement disorders constitute…
  • 2024 International Congress

    Parkinson Patients` Motor and Cognitive Functions are Improved by High Intensity LSVT®BIG Physiotherapy – a Randomized Prospective Pilot Trial

    B. Wimmer, B. Budeus, M. Katzer, C. Preiner, T. Wächter, K. Seppi, U. Bogdahn (Innsbruck, Austria)

    Objective: The objective of this pilot study was to evaluate the potential efficacy of high intensity physiotherapy LSVT®BIG on motor and non-motor functions of PD…
  • 2024 International Congress

    Investigating the Use of 18F-DOPA PET/CT to Improve Diagnosis and Clinical Management of Parkinson’s Disease in South Australian Movement Disorder Clinics.

    D. Sharma, M. Nottage, W. Vallat, R. Wilcox, M. Tan, N. Liam, A. Dwyer (Adelaide, Australia)

    Objective: Evaluate the impact of 18F-DOPA PET/CT on clinical management for Parkinsonism. Background: Parkinson’s Disease affects >100,000 people in Australia with an economic burden of…
  • 2024 International Congress

    Prevalence of Heterozygous ATP7B Mutation in Patients with Movement Symptoms

    Y. Kim, D. Park, J. Yoon (Suwon, Republic of Korea)

    Objective: The objective of our study is to elucidate the prevalence of heterozygous ATP7B mutation in patients with movement symptoms. We aim to determine whether…
  • 2024 International Congress

    Clinical and genetic characteristics of PLA2G6-parkinsonism in southwest of China and a review of heterogeneity of phenotype and genotype between Asian and Caucasian patients

    YF. Cheng, HF. Shang (Chengdu, China)

    Objective: Objective: To summarize clinical characteristics, imaging features and genetic data of PLA2G6 mutant patients in southwest of China, and to investigate the heterogeneity between Asian and…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley